Plasma Protein Manufacturing Plant
Therapure Biopharma Inc.
This large-scale production expansion to Therapure’s existing Meadowpine facility (designed by NXL in 2000) will support TBI’s Plasma Protein manufacturing unit. The two-storey expansion will connect with the existing production facility to maintain flows and leverage existing infrastructure. It features a side saddle utilities design which increases available production space, improves circulation, and allows for easy future vertical expansion, when required.
NXL worked with Therapure to determine the feasibility of the expansion, is leading the Site Plan Approval adjustment process, and worked with the owner through the programming and schematic design phase in 2016.
